New ways to fight HIV and AIDS

Cohan, Gary R.
April 1995
Advocate;4/4/95, Issue 678, p33
Highlights research findings in HIV treatment as of April 4, 1995. Debate over whether and when to start drug treatment for asymptomatic people with HIV infection; Mechanism of action of the HIV virus; Level of detectable HIV in the bloodstream of HIV-infected persons; Antiviral effects of drug combinations such as AZT and 3TC; Importance of early detection and intervention methods.


Related Articles

  • Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1.  // Annals of Internal Medicine;10/7/2014, Vol. 161 Issue 7, pI-22 

    The article presents questions and answers related to HIV-1 treatment including how was study done, researchers findings and limitations of the study.

  • CE/CME questions.  // AIDS Alert;Oct2007, Vol. 22 Issue 10, p119 

    A quiz about HIV infection and its treatment is presented.

  • Infectious diseases. Segreti, John // Patient Care;1/15/1998, Vol. 32 Issue 1, p102 

    Presents a study entitled `Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society--USA Panel,' by CCJ Carpenter, MA Fischl, SM Hammer, et al in the 1997 issue of the JAMA.

  • HAART therapy doubles in quarter.  // Medical Marketing & Media;Nov97, Vol. 32 Issue 11, p26 

    Reports on the increase in the number of newly diagnosed HIV patients being treated with the Highly Active Anti-Retroviral Therapy (HAART) in the second quarter of 1997. Data from IMS America.

  • One step forward, two steps back. Strathdee, Steffanie A.; Schechter, Martin T. // CMAJ: Canadian Medical Association Journal;12/15/97, Vol. 157 Issue 12, p1699 

    Examines progress and setbacks in HIV/AIDS research and treatment, especially in Canada, as of December 15, 1997. Advances in HIV therapies and survival rates; Drug resistance, rising incidence rates in some populations, and lack of access to treatments; Declines in rate of death in many...

  • Ray of hope in the AIDS war. Bartholet, Jeffrey // Newsweek (Pacific Edition);02/23/98 (Pacific Edition), Vol. 131 Issue 8, p5 

    Looks at a possible cure for HIV disease. The drug hydroxyurea (HU) in the treatment of HIV-positive patients; HU's effect on the number of nucleotides; Cost.

  • 3TC approved.  // AIDS Patient Care & STDs;Feb1996, Vol. 10 Issue 1, p48 

    Presents information on the approval of the HIV drug 3TC. How drug is to be used; Effects of drug.

  • SPV-30 shows encouraging results.  // AIDS Patient Care & STDs;Jun96, Vol. 10 Issue 3, p186 

    Reports on the progress of clinical trials held to evaluate the effectiveness of SPV-30 in the treatment of HIV infections. Mechanism of action of the drug; Decrease in the viral load after using the medication; Reported side effects of the drug.

  • Saquinavir combination results released.  // AIDS Patient Care & STDs;Aug96, Vol. 10 Issue 4, p261 

    Reports on the clinical trial comparing the combination of saquinavir (Invirase) and dideoxycytidine (ddc) versus each agent alone for the treatment of HIV-infection. Demonstration of the substantial survival benefit from combination therapy; Reduction of disease progression risk from...

  • Expanded access for delvaridine.  // AIDS Patient Care & STDs;Aug96, Vol. 10 Issue 4, p261 

    Reports on the availability of the antiretroviral agent delvaridine in an open-label program for use in combination with another antiretroviral agent in the treatment of HIV infection. Eligibility criteria.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics